Asia-Pacific Journal of Clinical Oncology
Издатель: Wiley · ISSN 17437555 · 72 статей
-
Latent Profile Analysis of Reproductive Concerns in Thyroid Cancer Survivors: Implications for Stratified Fertility Preservation Interventions
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Risk Factor Profiles May Differ Between Younger‐Onset and Late‐Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Transarterial Chemoembolization and Chemo‐Immunoembolization in Locally Advanced Rectal Cancer: An Updated Systematic Review
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Real‐World Toxicity and Outcomes of KEYNOTE‐522‐Style Neoadjuvant Pembrolizumab for Triple‐Negative Breast Cancer in Australia
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Divergent Trends in Head and Neck Cancer Burden in China (1990–2021)
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Re: “Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer.”
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Opioid Prescribing Changes in Advanced Cancer Before and After Withdrawal of Hydromorphone Slow‐Release Tablets
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Global Burden and Trends of Early‐Onset Tracheal, Bronchus, and Lung Cancer Among Women From 1990 to 2021
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Response Letter: Re: “Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer”
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Hyaluronan‐Mediated Motility Receptor Potentiates Colorectal Carcinoma Progression Through PI3K/AKT/mTOR Pathway Modulation
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
“It Will Only Work If Everyone is on Board”: A Needs and Context Assessment to Inform Exercise Oncology Implementation Within a Public Healthcare Organisation
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 870-880, December 2026.
-
Contribution of Focal 18F‐FDG Uptake on Positron Emission Tomography/Computed Tomography to Ultrasonography‐Based Malignancy Risk Assessment in Incidentally Detected Thyroid Nodules
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 861-869, December 2026.
-
The Importance of Driver‐Targeted Therapy Among Patients With Lung Cancer Initially Diagnosed in the Intensive Care Unit
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 844-852, December 2026.
-
Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 817-829, December 2026.
-
Ki‐67 Dynamics and Biomarker Conversion as Prognostic Factors in Residual Breast Cancer
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 808-816, December 2026.
-
The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 780-790, December 2026.
-
Efficacy of Neoadjuvant Denosumab on Tumor Recurrence, Ossification, and Surgical Outcomes in Patients With Grade III Giant Cell Tumor of Bone: A Prospective, Non‐Randomized Comparative Interventional Study
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 853-860, December 2026.
-
Real‐World Retrospective Analysis of Daratumumab for Relapsed or Refractory Multiple Myeloma in Regional Australia
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 840-843, December 2026.
-
A Single Center Review of Patients Undergoing High‐Dose Chemotherapy for Relapsed Germ‐Cell Tumors
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 830-839, December 2026.
-
Oncology Inpatient Resuscitation Planning and Long‐Term “Rapid Response Call” Outcomes
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 801-807, December 2026.
-
Evaluation of a Modified Proprietary Electronic Patient Reported Outcome Measures Tool for Monitoring Toxicities Associated With Systemic Chemotherapy
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 791-800, December 2026.
-
Prostate‐Specific Membrane Antigen Positron Emission Tomography in Japan: An Implementation Gap in the Era of Global Adoption
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 893-894, December 2026.
-
In Need of Rescue: Modernizing and Redefining Treatment Intent in Oncology
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 891-892, December 2026.
-
Issue Information
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 773-774, December 2026.
-
Translating COSA Psychosocial Guidelines into Practice: Learnings from a National Workshop on Post‐Acute Care for Adolescents and Young Adults with Cancer
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 775-779, December 2026.
-
Acute Toxicity With Trastuzumab Emtansine and Concurrent Radiotherapy: Non‐Consecutive Case Series
Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 881-890, December 2026.
-
Emerging Roles of Gold Nanoparticles in Lung Cancer Diagnosis and Imaging: A Promising yet Underexplored Frontier
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Minimum 7‐Year Follow‐Up of a Prospective Phase II Trial of Preoperative S‐1 Plus Oxaliplatin Chemotherapy for Clinical Stage III Gastric Cancer
Asia-Pacific Journal of Clinical Oncology, EarlyView.
-
Efficacy and Safety of CSF1R Inhibitors for Recurrent or Unresectable Tenosynovial Giant Cell Tumor: A Systematic Review and Meta‐Analysis of Phase III Randomized Controlled Trials
Asia-Pacific Journal of Clinical Oncology, EarlyView.